1
Fahrleitner-Pammer, A., Papaioannou, N., Gielen, E., Tepie, M. Feudjo, Toffis, C., Frieling, I., Geusens, P., Makras, P., Boschitsch, E., Callens, J., Anastasilakis, A. D., Niedhart, C., Resch, H., Kalouche-Khalil, L., Hadji, P.
Veröffentlicht in: Fahrleitner-Pammer , A , Papaioannou , N , Gielen , E , Tepie , M F , Toffis , C , Frieling , I , Geusens , P , Makras , P , Boschitsch , E , Callens , J , Anastasilakis , A D , Niedhart , C , Resch , H , Kalouche-Khalil , L & Hadji , P 2017 , ' Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium ' , Archives of Osteoporosis , vol. 12 , no. 1 , 58 . https://doi.org/10.1007/s11657-017-0351-2;
2017
Veröffentlicht in: Fahrleitner-Pammer , A , Papaioannou , N , Gielen , E , Tepie , M F , Toffis , C , Frieling , I , Geusens , P , Makras , P , Boschitsch , E , Callens , J , Anastasilakis , A D , Niedhart , C , Resch , H , Kalouche-Khalil , L & Hadji , P 2017 , ' Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium ' , Archives of Osteoporosis , vol. 12 , no. 1 , 58 . https://doi.org/10.1007/s11657-017-0351-2;
2017